MICHAEL RAPP
CIK 1405685 · President and Chairman · last filed 2023-10-03
MICHAEL RAPP is a President and Chairman who has filed 23 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing shows the insider was granted $1.5M of IMNM on Oct 3, 2023. Across all open-market trades the lifetime net is +$5.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $23.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$23.52M
2
23
$4.97M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMNM | Director | 1,279,914 | $18.38 | $23.52M | $3.33M | 10 | 2023-10-03 |
| Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | 10%+ Owner | 1,500,000 | $1.30 | $1.95M | $1.64M | 8 | 2018-05-31 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-10-03 | IMNM | Grant (A) | +253,806 | $1.50M | EDGAR |
| 2023-06-12 | IMNM | Grant (A) | — | $0 | EDGAR |
| 2023-01-17 | IMNM | Grant (A) | +17,500 | $70.0K | EDGAR |
| 2022-06-21 | IMNM | Grant (A) | — | $0 | EDGAR |
| 2021-09-14 | IMNM | Buy (P) | +25,962 | $518.2K | EDGAR |
| 2021-09-13 | IMNM | Buy (P) | +45,950 | $830.4K | EDGAR |
| 2021-06-01 | IMNM | Grant (A) | — | $0 | EDGAR |
| 2021-05-26 | IMNM | Buy (P) | +53,498 | $983.4K | EDGAR |
| 2020-11-05 | IMNM | Grant (A) | — | $0 | EDGAR |
| 2020-10-08 | IMNM | Mixed | +638,886 | $1000.0K | EDGAR |